Patriot Financial Group Insurance Agency’s Oncolytics Biotech ONCY Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,000	Closed	-$6K	–	1787
2020 Q1	$6K	Sell	4,000 -1,000	-20%	-$2.5K	﹤0.01%	1022
2019 Q4	$24K	Buy	+5,000	New	+$5.64K	0.01%	636
2018 Q4	–	Sell	-600	Closed	-$2K	–	1082
2018 Q3	$2K	Buy	+600	New	+$2.79K	﹤0.01%	865

Other funds holding ONCY

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Financial Consulate Hunt Valley, Maryland $899M AUM 20.23% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

BBVA

Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Patriot Financial Group Insurance Agency's ONCY Position: Q2 2020 in Review

Patriot Financial Group Insurance Agency sold out of Oncolytics Biotech (ONCY) in Q2 2020, closing a stake of 4,000 shares — an estimated $6K sold.

Patriot Financial Group Insurance Agency first reported a position in ONCY in Q3 2018 and held it in 3 quarters. The position peaked at $24K in Q4 2019. 35 funds tracked by Wall St. Rank hold ONCY as of Q2 2020.

Patriot Financial Group Insurance Agency reported no remaining Oncolytics Biotech position as of Q2 2020 after selling out during the quarter.
Patriot Financial Group Insurance Agency sold 4,000 Oncolytics Biotech shares in Q2 2020, an estimated $6K.
Patriot Financial Group Insurance Agency first reported a position in Oncolytics Biotech in Q3 2018 and held it in 3 quarters.
Patriot Financial Group Insurance Agency's Oncolytics Biotech position peaked at $24K in Q4 2019.
35 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2020.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q2 2020, filed 10 Jul 2020.